AURINIA PHARMACEUTICALS INC AUPH
ASignal's systematic analysis rates AUPH as Bullish.
Reflects the latest available analysis · analyzed Sep 16, 2026
The case on AUPH
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong free cash flow of $147.82M
- High gross margin of 77.88%
- Exceptional return on equity at 66.12%
- Low debt-to-equity ratio of 0.10x
- Current price near upper Bollinger Band, indicating momentum
- MACD above signal line with expanding histogram
- RSI at 57.78, approaching overbought territory
- High forward P/E of 15.90x relative to sector
- No Reddit mentions, suggesting limited retail interest
- Earnings growth may be unsustainable at 75.5% YoY
See the full verdict on AUPH
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes AUPH
Most investors never get a second opinion, let alone several. ASignal runs AUPH past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.